AcelRx Pharmaceuticals, Inc. Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| CORECAP ADVISORS, LLC | 02/10/2023 | 1.80 K | $4.07 K | -95.00% | 0.02% |
| BANK OF AMERICA CORP /DE/ | 02/10/2023 | 0 | $0 | -100.00% | 0.00% |
| WELLS FARGO & COMPANY/MN | 02/13/2023 | 0 | $0 | -100.00% | 0.00% |
| NORTHERN TRUST CORP | 02/13/2023 | 0 | $0 | -100.00% | 0.00% |
| TRUIST FINANCIAL CORP | 02/17/2023 | 0 | $0 | -100.00% | 0.00% |
| STATE STREET CORP | 05/15/2023 | 0 | $0 | -100.00% | 0.00% |
| VANGUARD GROUP INC | 02/10/2023 | 0 | $0 | -100.00% | 0.00% |
| FMR LLC | 02/13/2023 | 0 | $0 | -100.00% | 0.00% |
| CORNERSTONE CAPITAL, INC. | 02/13/2023 | 0 | $0 | -100.00% | 0.00% |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 02/13/2023 | 0 | $0 | -100.00% | 0.00% |
| GOLDMAN SACHS GROUP INC | 05/14/2024 | 0 | $0 | -100.00% | 0.00% |
| MORGAN STANLEY | 02/14/2023 | 0 | $0 | -100.00% | 0.00% |
| GROUP ONE TRADING, L.P. | 02/09/2023 | 0 | $0 | -100.00% | 0.00% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 02/14/2023 | 0 | $0 | -100.00% | 0.00% |
| NORTHWESTERN MUTUAL WEALTH MANAGEMENT CO | 02/21/2023 | 0 | $0 | -100.00% | 0.00% |
| BNP PARIBAS ARBITRAGE, SNC | 02/14/2023 | 0 | $0 | -100.00% | 0.00% |
| TWO SIGMA INVESTMENTS, LP | 02/14/2023 | 0 | $0 | -100.00% | 0.00% |
| GEODE CAPITAL MANAGEMENT, LLC | 02/13/2023 | 0 | $0 | -100.00% | 0.00% |
| TANG CAPITAL MANAGEMENT LLC | 02/14/2023 | 0 | $0 | -100.00% | 0.00% |
| MILLENNIUM MANAGEMENT LLC | 02/14/2023 | 0 | $0 | -100.00% | 0.00% |
| AVANTAX ADVISORY SERVICES, INC. | 02/13/2023 | 0 | $0 | -100.00% | 0.00% |
| BLACKROCK INC. | 02/13/2023 | 0 | $0 | -100.00% | 0.00% |
| BANK OF NEW YORK MELLON CORP | 02/14/2023 | 0 | $0 | -100.00% | 0.00% |
| LPL FINANCIAL LLC | 02/07/2023 | 0 | $0 | -100.00% | 0.00% |
| CAMBRIDGE INVESTMENT RESEARCH ADVISORS, INC. | 02/08/2023 | 0 | $0 | -100.00% | 0.00% |
| CITADEL ADVISORS LLC | 02/14/2023 | 0 | $0 | -100.00% | 0.00% |
| SIGMA PLANNING CORP | 01/24/2023 | 0 | $0 | -100.00% | 0.00% |
| TWO SIGMA SECURITIES, LLC | 02/14/2023 | 0 | $0 | -100.00% | 0.00% |
| SIMPLEX TRADING, LLC | 02/02/2023 | 0 | $0 | -100.00% | 0.00% |
| TOWER RESEARCH CAPITAL LLC (TRC) | 02/10/2023 | 0 | $0 | -100.00% | 0.00% |
| VIRTU FINANCIAL LLC | 02/15/2023 | 0 | $0 | -100.00% | 0.00% |
| CREATIVE PLANNING | 02/10/2023 | 0 | $0 | -100.00% | 0.00% |
| HUDOCK, INC. | 02/08/2023 | 0 | $0 | -100.00% | 0.00% |
| MACROVIEW INVESTMENT MANAGEMENT LLC | 01/11/2023 | 0 | $0 | -100.00% | 0.00% |
| ROCK SPRINGS CAPITAL MANAGEMENT LP | 02/14/2023 | 0 | $0 | -100.00% | 0.00% |
| UBS GROUP AG | 02/08/2023 | 0 | $0 | -100.00% | 0.00% |
| ENGINEERS GATE MANAGER LP | 02/14/2023 | 0 | $0 | -100.00% | 0.00% |
| JUNCTURE WEALTH STRATEGIES, LLC | 01/18/2023 | 0 | $0 | -100.00% | 0.00% |
| NEWEDGE ADVISORS, LLC | 02/14/2023 | 0 | $0 | -100.00% | 0.00% |
| AUSDAL FINANCIAL PARTNERS, INC. | 02/03/2023 | 0 | $0 | -100.00% | 0.00% |
| ADVISOR GROUP HOLDINGS, INC. | 02/10/2023 | 0 | $0 | -100.00% | 0.00% |
| AHRENS INVESTMENT PARTNERS LLC | 02/09/2023 | 0 | $0 | -100.00% | 0.00% |
| KOVACK ADVISORS, INC. | 02/22/2023 | 0 | $0 | -100.00% | 0.00% |
| CYPRESS CAPITAL, LLC | 12/26/2024 | 0 | $0 | -100.00% | 0.00% |
| MAYTECH GLOBAL INVESTMENTS, LLC | 02/14/2023 | 0 | $0 | -100.00% | 0.00% |
| GLOBAL RETIREMENT PARTNERS, LLC | 02/13/2023 | 0 | $0 | -100.00% | 0.00% |
| MAROTTA ASSET MANAGEMENT | 01/03/2023 | 0 | $0 | -100.00% | 0.00% |
| TEXAS CAPITAL BANK WEALTH MANAGEMENT SERVICES INC | 02/09/2023 | 0 | $0 | -100.00% | 0.00% |
| ONYX BRIDGE WEALTH GROUP LLC | 01/11/2023 | 0 | $0 | -100.00% | 0.00% |
| HERITAGE WEALTH MANAGEMENT, LLC | 02/13/2023 | 0 | $0 | -100.00% | 0.00% |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
AcelRx Pharmaceuticals, Inc. institutional Ownership - FAQ's
During the previous two years, 18 institutional investors and hedge funds held shares of AcelRx Pharmaceuticals, Inc.. The most heavily invested institutionals were:
EXANE DERIVATIVES: 0
LADENBURG THALMANN FINANCIAL SERVICES INC.: 9,076
Advisor Group, Inc.: 1,575
FNY Managed Accounts LLC: 0
Virtu KCG Holdings LLC: 118,675
CT Financial Advisors LLC: 300
0.02% of AcelRx Pharmaceuticals, Inc. stock is owned by institutional investors.
Institutional investors have bought a total of 2.71 M shares in the last 24 months. This purchase volume represents approximately $1.30 M in transactions.